ValiRx Plc is a biopharmaceutical company developing novel technologies and products in oncology therapeutics and diagnostics. The product focus is in the epigenomic analysis and treatment of cancer, but the technologies can be applied to other fields as well, such as neurology and inflammatory diseases.
Shares in Issue
Live Quote
 
 

ValiRx plc is a company incorporated in the United Kingdom under the Companies Act 1985, its principle place of business is in the United Kingdom. 

The Total Number of shares in issue is 136,478,365.  The percentage of securities not in public hands is 10.5%. The shareholders who hold more than 3% are as follows:

Number of shares Percentage of total

Fitel Nominees Ltd 

 45,500,000  33.3%
Pershing Nominees Ltd 16,370,903 12%
Dr Satu Vainikka   5,358,507 3.9%
Dr Jacob Micallef   4,104,340 3%

Please click on the link to view the Certificate of Registration for the reduction of capital agreed at the last AGM.